Compare RNA & PLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNA | PLG |
|---|---|---|
| Founded | 2025 | 2000 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 140.7M |
| IPO Year | 2025 | 2002 |
| Metric | RNA | PLG |
|---|---|---|
| Price | $6.45 | $0.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | 205.6K | ★ 1.1M |
| Earning Date | 11-12-2026 | 11-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $104.53 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.47 | $0.95 |
| 52 Week High | $73.06 | $4.04 |
| Indicator | RNA | PLG |
|---|---|---|
| Relative Strength Index (RSI) | 24.72 | 36.04 |
| Support Level | N/A | $0.95 |
| Resistance Level | $8.50 | $1.44 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 1.49 | 16.92 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Platinum Group Metals Ltd is a development-stage company, conducts work on mineral properties it has staked or acquired by way of option agreements in the Republic of South Africa. Key metals of economic interest on the company's mineral properties include platinum, palladium, rhodium, gold, copper, and nickel. The company operates in one segment, the development of the Waterberg Project in South Africa, and geographically in Canada and South Africa.